2015
DOI: 10.1107/s160057751501766x
|View full text |Cite
|
Sign up to set email alerts
|

A feasibility study of X-ray phase-contrast mammographic tomography at the Imaging and Medical beamline of the Australian Synchrotron

Abstract: Results are presented of a recent experiment at the Imaging and Medical beamline of the Australian Synchrotron intended to contribute to the implementation of low-dose high-sensitivity three-dimensional mammographic phase-contrast imaging, initially at synchrotrons and subsequently in hospitals and medical imaging clinics. The effect of such imaging parameters as X-ray energy, source size, detector resolution, sample-to-detector distance, scanning and data processing strategies in the case of propagation-based… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
38
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 40 publications
(39 citation statements)
references
References 27 publications
1
38
0
Order By: Relevance
“…The results presented here refer to a study performed at the SYnchrotron Radiation for MEdical Physics (SYRMEP) beamline of the ELETTRA synchrotron light source (Basovizza -Trieste, Italy), which is so far the only synchrotron beamline where trials on human patients have been already conducted in 2D projection mammography mode [17][18][19]. In this framework the SYRMA-CT (SYnchrotron Radiation for MAmmography) project aims to set-up a new clinical trial of PhC breast CT with synchrotron radiation in near future [20].…”
Section: Introductionmentioning
confidence: 99%
“…The results presented here refer to a study performed at the SYnchrotron Radiation for MEdical Physics (SYRMEP) beamline of the ELETTRA synchrotron light source (Basovizza -Trieste, Italy), which is so far the only synchrotron beamline where trials on human patients have been already conducted in 2D projection mammography mode [17][18][19]. In this framework the SYRMA-CT (SYnchrotron Radiation for MAmmography) project aims to set-up a new clinical trial of PhC breast CT with synchrotron radiation in near future [20].…”
Section: Introductionmentioning
confidence: 99%
“…Understanding this point is very important in order to appreciate the difference between the PB‐CT method employed in the present study and any form of image processing that can be utilized in conjunction with conventional absorption‐based CT. While the latter cannot improve SNR in the reconstructed slices without sacrificing the spatial resolution or increasing the x‐ray dose, PB‐CT is capable of achieving this goal, as demonstrated earlier and discussed further below.…”
Section: Methodsmentioning
confidence: 93%
“…However, if γ varies across the sample, as is generally the case for breast tissues, the application of the TIE‐Hom method with γ=constant (as in the present study) to a propagated image may result in incomplete compensation of phase‐contrast effects in some areas and excessive blurring in other areas. As these effects have been studied and explained in detail elsewhere, we will not discuss them further here.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…X-ray mammography, in particular, has been recognised as the area of medical radiography which stands to gain the most from application of phase-contrast because X-ray phase-contrast provides the maximum advantage over conventional absorption-based imaging when applied to high-resolution imaging of soft tissues (such as that within the breast) 5 . Recent publications have studied the performance of different variants of phase-contrast imaging of breast tissues both theoretically and experimentally on the basis of feasibility studies carried out at Elettra and at the Australian Synchrotron [7][8][9][10][11] . At Elettra, a program aiming to implement a PCT trial using a new, single photon counting detector is ongoing, as a continuation of the first protocol of in-line phase-contrast planar mammography carried out at the beginning of the 2000s.…”
Section: Introduction 11 Backgroundmentioning
confidence: 99%